Logo Smart Immune

Smart Immune

Société | Paris, France

Onglets principaux

A propos de votre organisation

Smart Immune is a clinical stage French biotech company developing a new type of cell therapy: ProTcell. Our mission is to fully and rapidly re-arm the immune system to fight against infections and cancer.


ProTcell technology in short:

- T-cell progenitors-based therapy providing polyclonal T-cell compartment in 3 months vs 18 months in human physiology.

- Thymus-empowered platform designed to provide self-tolerant T-cells not causing GvHD.

- Unique & patented cell culture manufacturing process creating an off-the-shelf scalable production model.

- Large platform potential with innovative pipeline across multiple Immuno-Oncology therapies in haematological and solid tumours (BiTES, Immune Checkpoint Inhibitors, CAR-T, etc.) enabling allogenic long lasting clinical outcome.


Smart Immune Quick Momentum:

  • - Promising first clinical data in EU/US phase I/II initiated on acute leukemic patients and severe immuno-combined deficiencies.
  • - Significant investments from blue-chip partners: €23m raised to date.
  • - Strong and experienced management team and co-founded by world leading cell-therapy experts.
  • - First equity investment of the Bill & Melinda Gates Foundation in France.
  • - Laureate of the European Innovation Council (EIC) accelerator funding with a €2.5m grant and an equity commitment to the forthcoming Series A.
  • - Selected among the 20 most promising French Biotech by the French Government: Health20.

Réseau (0)

Il n'y a pas encore d'organisations dans le réseau.

Activité récente

Vous n'êtes pas connecté(e)

Un certain nombre de contenus vous sont cachés et vous ne bénéficiez pas des fonctionnalités de mises en relation.

Log in or register pour accéder à l’intégralité des contenus et fonctionnalités d’EuroQuity : l’inscription est rapide et gratuite !